Conclusion GLP-2 can promote recovery of small intestinal epithelia from radiation injury in mice.
结论胰高血糖素样肽- 2可促进放射损伤小鼠肠上皮的恢复。
Objective To study the effects of GLP-2 on modulation of intestinal mucosa epithelium tight junction in obstructive jaundice rats.
目的探讨类高血糖素多肽- 2 (GLP - 2)对实验性梗阻性黄疸小肠上皮细胞紧密连接的调控。
Two trials were conducted to study Glucagon-like peptide 2 secretion in postweaning piglets and the effect of immune challenge on gut development and GLP-2 level.
通过2个试验研究了断奶仔猪胰高血糖素-2（GLP-2）的分泌规律和免疫应激对断奶仔猪肠道发育及GLP-2分泌的影响。
BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.
百泌达是FDA批准的治疗2型糖尿病的首个GLP - 1受体激动剂药物。
We conducted this study to investigate the effect of a combination therapy with GLP-1 and metformin, which could theoretically be additive, in type 2 diabetic patients.
我们进行这项研究，以观察glp - 1和二甲双胍联合治疗的效果，在2型糖尿病患者理论上是联合治疗具有叠加效果。
Objective To investigate the effects of glucagon like peptide 2 (GLP 2) on recovery of small intestinal epithelia from radiation injury in mice.
目的探讨胰高血糖素样肽2对放射损伤小鼠肠上皮恢复的影响。
This would be the breakthrough if we can find drugs and agents to prevent the progression of type 2 diabetes and of course GLP 1 based on animal studies have very interesting effects.
如果我们能发现可以用来预防2型糖尿病进展的药物那将会是个突破，当然基于动物研究结果，GLP -1有令人非常感兴趣的效应。
Of course during treatment the potentiation of GLP-1 activity is very important but in terms of it's physiological and pathophysiological role in type 2 diabetes there is no clear robust evidence.
从治疗角度讲，增强机体GLP - 1活性非常重要，但目前尚无GLP - 1活性对2型糖尿病发病的生理和病理生理学作用的确定证据。
Of course during treatment the potentiation of GLP-1 activity is very important but in terms of it's physiological and pathophysiological role in type 2 diabetes there is no clear robust evidence.
从治疗角度讲，增强机体GLP - 1活性非常重要，但目前尚无GLP - 1活性对2型糖尿病发病的生理和病理生理学作用的确定证据。
应用推荐